Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer

被引:0
|
作者
Eckhoff, Austin [1 ]
Kanu, Elishama [2 ]
Fletcher, Ashley [2 ]
Bao, Matthew [2 ]
Nussbaum, Daniel P. [3 ]
Blazer, Dan G., III [3 ]
Lidsky, Michael E. [3 ]
Zani, Sabino [3 ]
Shah, Kevin [4 ]
Aushev, Vasily
Krinshpun, Shifra
Jurdi, Adham
Liu, Minetta
Allen, Peter J. [5 ]
Herbert, Garth [4 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Durham, NC USA
[3] Duke Univ, Surg, Med Ctr, Durham, NC USA
[4] Duke Univ, Surg, Durham, NC USA
[5] Duke Univ, Med Ctr, Div Surg Oncol, Durham, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P33
引用
收藏
页码:S76 / S76
页数:1
相关论文
共 50 条
  • [1] Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
    Austin M. Eckhoff
    Elishama Kanu
    Ashley Fletcher
    Matthew Bao
    Vasily N. Aushev
    Erik Spickard
    Daniel P. Nussbaum
    Peter J. Allen
    [J]. Annals of Surgical Oncology, 2024, 31 : 1444 - 1446
  • [2] Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
    Eckhoff, Austin M.
    Kanu, Elishama
    Fletcher, Ashley
    Bao, Matthew
    Aushev, Vasily N.
    Spickard, Erik
    Nussbaum, Daniel P.
    Allen, Peter J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1444 - 1446
  • [3] Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer
    Li, Shengnan
    Zhang, Gengpu
    Li, Xin
    Li, Xiaojie
    Chen, XiaoBing
    Xu, Yu
    Ren, He
    [J]. PHARMACOGENOMICS, 2021, 22 (11) : 657 - 668
  • [4] Clinical utility of circulating tumor DNA in resectable and advanced pancreatic cancer
    Popova, A.
    Fedyanin, M.
    Pokataev, I.
    Shamovskaya, D.
    Kudashkin, N.
    Boyarskikh, U.
    Kechin, A.
    Oscorbin, I.
    Moroz, E.
    Trigolosov, A.
    Filipenko, M.
    Podluzhnyi, D.
    Tjulandin, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S180 - S181
  • [5] Comparative levels of KRAS mutations circulating tumor DNA for association with overall survival in patients with non-resectable pancreatic cancer
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Hassaine, Latifa
    Samuelsz, Errin
    Chen, Inna
    Collisson, Eric A.
    Calatayud, Dan
    Jensen, Benny V.
    Hasselby, Jane Preuss
    Lu, Timothy T.
    Poole, Jason C.
    Melnikova, Vlada
    Erlander, Mark G.
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Temporal changes in circulating tumor cells and circulating tumor DNA in patients with resectable pancreatic ductal adenocarcinoma
    Zhang, Yang
    Dopico, Pablo J.
    Le, Minh-Chau N.
    Yang, Zhijie
    Wang, Youxiang
    Rogers, Sherise C.
    George, Thomas J.
    Fan, Hugh Z.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [7] LEClinical Utility of Comprehensive Sequencing of Circulating Tumor DNA in Resectable Pancreatic Cancer
    Imamura, Taisuke
    Ashida, Ryo
    Sugiura, Teiichi
    Ohgi, Katsuhisa
    Yamada, Mihoko
    Otsuka, Shimpei
    Uesaka, Katsuhiko
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S285 - S285
  • [8] Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
    Tyerman, Zachary
    Ambler, Emily
    Schlick, Cary Jo R.
    Nwajei, Felix
    Chawla, Akhil
    [J]. JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [9] Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer
    Imamura, Taisuke
    Ashida, Ryo
    Urakami, Kenichi
    Ohshima, Keiichi
    Uesaka, Katsuhiko
    Sugiura, Teiichi
    Okamura, Yukiyasu
    Ohgi, Katsuhisa
    Yamada, Mihoko
    Otsuka, Shimpei
    Nagashima, Takeshi
    Sugino, Takashi
    Akiyama, Yasuto
    Yamaguchi, Ken
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (03)
  • [10] Circulating tumor DNA analysis to detect minimal residual disease and predict recurrence in patients with resectable pancreatic cancer.
    Yang, Liu
    Jiang, Jiahong
    Ye, Song
    Xu, Yaping
    Huang, Dongsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)